Gene therapy for ischemic heart disease

By Hinkel Rabea   Trenkwalder Teresa   Kupatt Christian  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 723-737

Informa Healthcare

Access to resources Recommend Favorite

Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure

By Wen Yanting   Chen Bing   Wang Chen   Ma Xiaodong   Gao Qian  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1563-1573

Informa Healthcare

Access to resources Recommend Favorite

Angiogenic strategy for human ischemic heart disease: Brief overview

By Fukuda Shoji   Yoshii Shinpei   Kaga Shigeaki   Matsumoto Masahiko   Kugiyama Kiyotaka   Maulik Nilanjana  

Molecular and Cellular Biochemistry, Vol. 264, Iss. 1-2, 2004-09 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite

Ethane and n-pentane in exhaled breath are biomarkers of exposure not effect

By Gorham Katrine   Sulbaek Andersen Mads P.   Meinardi Simone   Delfino Ralph   Staimer Norbert   Tjoa Thomas   Rowland F. Sherwood   Blake Donald  

Biomarkers, Vol. 14, Iss. 1, 2009-02 ,pp. : 17-25

Informa Healthcare

Access to resources Recommend Favorite

Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke - The role of peroxidase and lecithin:cholesterol acyltransferase

By Polidori M.C.   Frei B.   Cherubini A.   Nelles G.   Rordorf G.   Keaney J.F.   Schwamm L.   Mecocci P.   Koroshetz W.J.   Beal M.F.  

Free Radical Biology and Medicine, Vol. 25, Iss. 4, 1998-09 ,pp. : 561-567

Elsevier

Access to resources Recommend Favorite